FY2025 · ended Sep 30, 2025 · Revenue $17,000 · Filed Dec 29, 2025
Bodhi Tree Biotechnology Inc. (BDTB) files with the SEC under industry code 8742, Services-Management Consulting Services. In fiscal 2025, which ended Sep 30, 2025, it reported revenue of $17,000 and a net loss of $149,666.
Revenue (TTM)
$37,000
Net income (TTM)
$-116,025
Operating cash flow (TTM)
$-115,530
Free cash flow
—
EPS (TTM)
$-0.00
Dividend per share
None
Shares outstanding
25.44M
Net cash
—
Operating margin
-310.2%
FY 2026
Company profile
- Industry
- Services-Management Consulting Services (SIC 8742)
- Listed as
- BDTB (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Danville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2041531
Other Services-Management Consulting Services companies
- Cgi Inc GIB
- Booz Allen Hamilton Holding Corp BAH
- Genpact LTD G
- Fti Consulting, Inc FCN
- Exponent Inc EXPO
- Huron Consulting Group Inc. HURN
- Astrana Health, Inc. ASTH
- ICF International, Inc. ICFI
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
|---|---|
| Revenue | $17,000 |
| Operating income | -$147,618 |
| Net income | -$149,666 |
| Diluted EPS | -$0.01 |
| Operating cash flow | -$150,166 |
| Total assets | $119,161 |
| Stockholders' equity | $119,161 |
| Cash and investments | $109,404 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Dec 29, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q/A | Amended quarterly report | Jul 28, 2025 | Mar 31, 2025 |
All 26 Bodhi Tree Biotechnology Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.